Reagent kit for determining the concentration of triglycerides in blood serum and plasma (TRIGLYCERIDES-1-OLVEX) as per TU 9398-053-44276594-2010
Russia·215410·OLVEX DIAGNOSTICS LLC·Registered December 27, 2022·N/A- Device Name (English)
- Reagent kit for determining the concentration of triglycerides in blood serum and plasma (TRIGLYCERIDES-1-OLVEX) as per TU 9398-053-44276594-2010
- Device Name (Russian)
- Набор реагентов для определения концентрации триглицеридов в сыворотке и плазме крови (ТРИГЛИЦЕРИДЫ-1-ОЛЬВЕКС) по ТУ 9398-053-44276594-2010
- Device Type (English)
- N/A
- Device Type (Russian)
- 215410
- Risk Class
- N/A
- OKPD Code
- 21.20.23.110
- Registry Key
- 68120.0
- Registration Number
- ФСР 2011/10265
- Registration Date
- December 27, 2022
- Manufacturer Name (English)
- OLVEX DIAGNOSTICS LLC
- Manufacturer Name (Russian)
- ООО "ОЛЬВЕКС ДИАГНОСТИКУМ"
- Country (English)
- Russia
- Country (Russian)
- Россия
- Legal Address (English)
- OLVEX DIAGNOSTICUM LLC, 10 Oktyabrskaya nab., bldg. 1, bldg. 1, St. Petersburg, 193091 Russia
- Legal Address (Russian)
- ООО "ОЛЬВЕКС ДИАГНОСТИКУМ", Россия, 193091, Санкт-Петербург, Октябрьская наб., д. 10, к. 1, стр. 1
- Manufacturing Address
- 199155, Россия, Санкт-Петербург, пер. Декабристов, д. 5/17, кв. 1
Access comprehensive regulatory information for Reagent kit for determining the concentration of triglycerides in blood serum and plasma (TRIGLYCERIDES-1-OLVEX) as per TU 9398-053-44276594-2010 in the Russia medical device market through Pure Global AI's free database. This medical device is registered under Roszdravnadzor registration number ФСР 2011/10265 and manufactured by OLVEX DIAGNOSTICS LLC. The device was registered on December 27, 2022.
This page provides complete registration details including device type, manufacturer information, country of origin (Russia), and regulatory compliance data from the official Russia Roszdravnadzor medical device database. Pure Global AI offers free access to Russia's complete medical device registry, helping global MedTech companies navigate Roszdravnadzor regulations efficiently.